12697881

Source:http://linkedlifedata.com/resource/pubmed/id/12697881

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016410, umls-concept:C0042845, umls-concept:C0087111, umls-concept:C0210657, umls-concept:C0282460, umls-concept:C0812413
pubmed:issue	8
pubmed:dateCreated	2003-4-16
pubmed:abstractText	This phase II clinical study evaluated the efficacy of pemetrexed for the treatment of malignant pleural mesothelioma (MPM).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Folic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Folic Acid Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Glutamates, http://linkedlifedata.com/resource/pubmed/chemical/Guanine, http://linkedlifedata.com/resource/pubmed/chemical/Hematinics, http://linkedlifedata.com/resource/pubmed/chemical/pemetrexed
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0732-183X
pubmed:author	pubmed-author:BlatterJohannesJ, pubmed-author:BurrisHowardH, pubmed-author:GatzemeierUlrichU, pubmed-author:KepplerUweU, pubmed-author:KindlerHedy LHL, pubmed-author:ManegoldChristianC, pubmed-author:RusthovenJames JJJ, pubmed-author:ScagliottiGiorgio VGV, pubmed-author:ShinDong-MDM, pubmed-author:SymanowskiJames TJT, pubmed-author:VasconcellesMichael JMJ
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1556-61
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:12697881-Adult, pubmed-meshheading:12697881-Aged, pubmed-meshheading:12697881-Aged, 80 and over, pubmed-meshheading:12697881-Antimetabolites, Antineoplastic, pubmed-meshheading:12697881-Drug Administration Schedule, pubmed-meshheading:12697881-Female, pubmed-meshheading:12697881-Folic Acid, pubmed-meshheading:12697881-Folic Acid Antagonists, pubmed-meshheading:12697881-Follow-Up Studies, pubmed-meshheading:12697881-Glutamates, pubmed-meshheading:12697881-Guanine, pubmed-meshheading:12697881-Hematinics, pubmed-meshheading:12697881-Humans, pubmed-meshheading:12697881-Leukopenia, pubmed-meshheading:12697881-Male, pubmed-meshheading:12697881-Mesothelioma, pubmed-meshheading:12697881-Middle Aged, pubmed-meshheading:12697881-Neutropenia, pubmed-meshheading:12697881-Pleural Neoplasms, pubmed-meshheading:12697881-Survival Analysis, pubmed-meshheading:12697881-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
pubmed:affiliation	University of Turin, Department of Clinical and Biological Sciences, Azienda Ospedaliera S. Luigi, Regione Gonzole 10, 10043 Orbassano (Torino) Italy. scagliotti@ihnet.it
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study, Clinical Trial, Phase II